|Chemical name: Glipizide
Brand name: Glucotrol
Typical dosage: 10mg
Typical type: Tablet1
Glipizide is a medication used to treat type 2 diabetes. Glipizide is available as a brand name or generic drug and comes as an oral tablet in immediate release and extended release formulations.
Glipizide is a medication used to improve blood sugar levels in adults with type 2 diabetes. The brad name equivalent of Glipizide is called Glucotrol.
Glipizide is typically taken 1 to 3 times daily. Your dose may be increased as needed until your blood sugar is more controlled.
Glipizide helps your pancreas release insulin, reduces how much sugar your liver releases into your body and increases your sensitivity to insulin.
Major side effects of glipizide include dizziness, diarrhea, low blood sugars, excitability and gas.
Yes! 100% of Medicare Advantage plans and Medicare Part D plans cover Glipizide.1
Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Glipizide.
Find Medicare Advantage plans with drug coverageCompare Plans
Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.
Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.
|Deductible stage||Typical copay stage|
|Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.
In the deductible stage, you’re responsible for the full cost of your prescription drugs.
Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.
|After you meet your Part D deductible, you enter the initial coverage period.
During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
|Free– $9||Free – $9|
If you are taking the immediate release tablet, take your dose 30 minutes before meals. If you are taking the extended release tablet, take with the first meal of the day.
Glipizide can cause low blood sugars. You can tell if your blood sugar is low if you experience symptoms such as shakiness, sweatiness, hunger, fatigue, dizziness, increased heartbeat, confusion or headache, or if your blood sugar readings are below 70 mg/dL.
If you experience low blood sugar while taking Glipizide, you can eat or drink 15g of carbohydrates, wait 15 minutes and recheck your blood sugar. If your blood sugar is still low, you can repeat the above.
If you experience many episodes of low blood sugar while taking Glipizide, talk to your doctor, as you may need an adjustment to your medications or doses.
This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.
Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.
Written by Hayden Gharibyar, Pharm.D.
Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.
1 GoodRx. Glipizide. Retrieved Sep. 2019, from www.goodrx.com/glipizide.
2 Jacobson, Gretchen; et al. A Dozen Facts About Medicare Advantage. (Nov. 13, 2018). Kaiser Family Foundation. Retrieved from www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage.
MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.
Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
Medicare has neither reviewed nor endorsed this information.